Search

everythinglearnresearchcommunity

for

Search:↓

Blocking TGFβ can help treat fibrotic skin conditions by promoting fat cell formation.

Keratin-based hydrogels with calcium are effective for delivering anti-fibrotic drugs.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.

Acyclovir cream may slow down hair growth, suggesting it could be a new treatment for excessive hairiness.

Targeting the narrowest part of the anterior chamber angle may help prevent pupil block in glaucoma.

A specific metabolite, not a receptor protein, triggers the production of certain kidney enzymes, but this process is disrupted in mice with a mutation causing testicular feminization.

Tamsulosin's sulfonamide group may contribute to floppy iris syndrome.

Intravenous calcium therapy is a safe and effective treatment for a rare type of rickets.

New genotype linked to non-classical congenital adrenal hyperplasia found in Italian siblings.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

Lack of vitamin D receptor causes hair loss in mice by allowing certain genes to overactivate.

A new anti-baldness patch effectively treats hair loss by blocking enzymes linked to the condition.

Social isolation makes rats more sensitive to alcohol's effects on the brain.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Disrupting the FGF5 gene in rabbits leads to longer hair by extending the hair growth phase.

5-alpha reductase inhibitors help with benign prostatic hyperplasia but don't cure it, and more research is needed.

Potassium channel openers show promise for treating heart disease and other conditions, but more research is needed to fully understand their effects and safety.

IMSG nanoparticles improve vaccine delivery and immune response through hair follicles.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

Skin problems like itching, dry skin, and hair loss are more common in hepatitis C patients after interferon treatment, but lichen planus is not linked to the infection.

JAK inhibitors offer new hope for treating severe alopecia areata.

Combining β-sitosterol nanoparticles with laser therapy may effectively stimulate hair growth in androgenetic alopecia.

New treatments for male hypogonadism are effective and should be personalized.

Vitamin D receptor may help protect against UV-induced skin cancer.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Long-term use of calcineurin inhibitors in transplant patients can cause hormone issues that can be managed with proper care.

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

Patients with both connective tissue disease and acid reflux are more likely to have certain symptoms and physical signs.